Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose MMF and Tacrolimus for Refractory Lupus Nephritis
NCT01203709Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil and tacrolimus in lupus nephritis (LN), sponsored by Tuen Mun Hospital. Primary endpoint: Clinical remission rate at 12 months. Started Aug 2010; status: completed.
02
Drugs
mycophenolate mofetiltacrolimus
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01203709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203709.